Related Experiment Video
Updated: Dec 19, 2025

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Improving Outcomes Among Young Adults with type 1 diabetes: The D1 Now Randomised Pilot Study Protocol.
This pilot study tested the D1 Now intervention for young adults with type 1 diabetes, aiming to improve glycaemic control and reduce complications. Findings will refine the intervention and assess feasibility for a larger randomized control trial.
Area of Science:
- Endocrinology and Metabolism
- Public Health
- Digital Health
Background:
- Young adults (18-25) with type 1 diabetes often experience suboptimal glycemic control, increasing long-term complication risks.
- A complex intervention, D1 Now, was developed using health psychology and a patient-centered approach.
- D1 Now integrates a support worker, interactive messaging, and an agenda-setting tool for clinic consultations.
Purpose of the Study:
- To evaluate the acceptability and feasibility of the D1 Now intervention in young adults with type 1 diabetes.
- To gather data for refining the D1 Now intervention.
- To determine the feasibility of conducting a definitive Randomized Control Trial (RCT) for this intervention.
Main Methods:
- A pilot study involving diabetes clinics across Ireland, randomizing participants aged 18-25 with type 1 diabetes (≥12 months) to D1 Now or usual care.
- Outcome measures include HbA1c, clinic attendance, severe hypoglycemia/DKA episodes, diabetes distress, self-management, quality of life, and perceived control.
- Data collection involves baseline and 12-month follow-up for descriptive statistics, alongside fidelity assessment, health economic analysis, and a qualitative sub-study.
Main Results:
- Pilot study data collection and analysis are ongoing.
- Acceptability and feasibility metrics will guide intervention refinement.
- Feasibility for a full RCT will be assessed based on recruitment, retention, and outcome data.
Conclusions:
- The D1 Now intervention shows promise for improving outcomes in young adults with type 1 diabetes.
- This pilot study is crucial for informing the design of a definitive RCT.
- Further research is needed to confirm the efficacy of D1 Now in a larger trial.
More Related Videos
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
06:27Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Bioavailability Study Design: Healthy Subjects Versus Patients
Diabetes: Symptoms, Diagnosis, and Complications